Profiling the Targets of Protective CD8 + T Cell Responses to Infection

T cells are critical effectors of host immunity that target intracellular pathogens, such as the causative agents of HIV, tuberculosis, and malaria. The development of vaccines that induce effective cell-mediated immunity against such pathogens has proved challenging; for tuberculosis and malaria, m...

Full description

Saved in:
Bibliographic Details
Published inMolecular therapy. Methods & clinical development Vol. 7; no. C; pp. 20 - 31
Main Authors Bruder, Joseph T, Chen, Ping, Ekberg, Greg, Smith, Emily C, Lazarski, Christopher A, Myers, Bennett A, Bolton, Jessica, Sedegah, Martha, Villasante, Eileen, Richie, Thomas L, King, C Richter, Aguiar, Joao C, Doolan, Denise L, Brough, Douglas E
Format Journal Article
LanguageEnglish
Published United States Elsevier Limited 15.12.2017
American Society of Gene & Cell Therapy
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:T cells are critical effectors of host immunity that target intracellular pathogens, such as the causative agents of HIV, tuberculosis, and malaria. The development of vaccines that induce effective cell-mediated immunity against such pathogens has proved challenging; for tuberculosis and malaria, many of the antigens targeted by protective T cells are not known. Here, we report a novel approach for screening large numbers of antigens as potential targets of T cells. Malaria provides an excellent model to test this antigen discovery platform because T cells are critical mediators of protection following immunization with live sporozoite vaccines and the specific antigen targets are unknown. We generated an adenovirus array by cloning 312 highly expressed pre-erythrocytic antigens into adenovirus vectors using high-throughput methodologies. The array was screened to identify antigen-specific CD8 T cells induced by a live sporozoite vaccine regimen known to provide high levels of sterile protection mediated by CD8 T cells. We identified 69 antigens that were targeted by CD8 T cells induced by this vaccine regimen. The antigen that recalled the highest frequency of CD8 T cells, PY02605, induced protective responses in mice, demonstrating proof of principle for this approach in identifying antigens for vaccine development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present Address: PATH’s Malaria Vaccine Initiative, 455 Massachusetts Avenue NW, Suite 1000, Washington, DC 20001, USA
Present Address: Summit Consulting, 567 Chestertown Street, Gaithersburg, MD 20878, USA
ISSN:2329-0501
2329-0501
DOI:10.1016/j.omtm.2017.08.003